Paediatric Validating Injury Burden Estimates Study (VIBES-Junior)
Funder
National Health and Medical Research Council
Funding Amount
$484,562.00
Summary
Injury is a leading cause of death and disability in children and adolescents, and can have lifelong effects for survivors. This study will quantify how well children recover from injury, and how long this takes, to establish better measures of the population impact of injury sustained in childhood and adolescence. The findings will be used to inform future health and social policy concerning primary prevention of injury in childhood and adolescence and the provision of services after injury.
Pathways To Avoidable And Unexplained Deaths In The Early Lifecourse
Funder
National Health and Medical Research Council
Funding Amount
$1,108,086.00
Summary
There continues to be unacceptable numbers of avoidable deaths in early life in Australia, particularity among disadvantaged groups. This project will use novel, large-scale population data to identify and quantify the impact of risks to early life mortality and preventable pathways. This new knowledge will inform new strategies to prevent stillbirth and child deaths for the benefit of Aboriginal and Torres Strait Islander and other populations.
Risk Of Recurrence After Diagnosis Of Invasive Breast Cancer By Molecular Subtype As Defined By ER, PR And Her2 Status
Funder
National Health and Medical Research Council
Funding Amount
$500,622.00
Summary
Breast cancer is a heterogeneous disease. Molecular subtypes have been identified that differ in terms of prognosis and response to treatment. This study aims to estimate recurrence free survival of breast cancer by molecular subtypes in a population-based sample of Australian women. The results will assist clinicians to guide their therapeutic decisions and will inform women about their anticipated outcome after diagnosis of breast cancer.
Statistical Analysis Of An International 10 Year Prospective Family Study Of Gene-environment Interactions On Risk Of Female Breast Cancer.
Funder
National Health and Medical Research Council
Funding Amount
$450,198.00
Summary
This study will provide new and credible information on how the effects of environmental and lifestyle factors on breast cancer risk depend on a woman's underlying genetic susceptibility using a large, international 10 year prospective family study.
Vaccination Timeliness In Aboriginal And Non-Aboriginal Infants: Risk Factors For Delayed Vaccination And Impact On Disease Burden—a Record Linkage Study
Funder
National Health and Medical Research Council
Funding Amount
$538,183.00
Summary
Vaccination has had a significant impact, but preventable infections continue to occur, perhaps due to delayed uptake of scheduled doses. For the first time, we will link vaccination and other health records to: provide accurate estimates of the impact of vaccination; identify reasons for delayed vaccination; and quantify the expected reduction in disease burden if vaccination timeliness was improved. The study will help determine who would benefit most from efforts to improve timeliness.
Evaluation Of Outcomes And Cost-effectiveness Of Implementing Next Generation Human Papillomavirus (HPV) Vaccination And Associated Primary HPV-based Cervical Cancer Screening Strategies In Australia
Funder
National Health and Medical Research Council
Funding Amount
$697,071.00
Summary
This project involves using simulation modelling to predict the effect of the next generation human papillomavirus (HPV) vaccine, which will protect against infection with more strains of HPV. The investigators will use large datasets garnered from around the world to inform the assessment of the cost-effectiveness of this new vaccine in Australia and other key countries, and also to assess whether cervical screening will need to change in the future to account for the introduction of the new va ....This project involves using simulation modelling to predict the effect of the next generation human papillomavirus (HPV) vaccine, which will protect against infection with more strains of HPV. The investigators will use large datasets garnered from around the world to inform the assessment of the cost-effectiveness of this new vaccine in Australia and other key countries, and also to assess whether cervical screening will need to change in the future to account for the introduction of the new vaccine.Read moreRead less
POPULATION-LEVEL RELEVANCE OF RISK FACTORS FOR CANCER
Funder
National Health and Medical Research Council
Funding Amount
$319,692.00
Summary
This research will provide novel up-to-date evidence-based information on the population-level relevance of lifestyle-related risk factors for cancer in Australia, by applying an advanced disease burden measure to established Australian cohort studies. This knowledge on the national cancer burden is essential for targeting cancer interventions for those at highest risk and evaluating their effectiveness.
Developing A System For Comprehensive Quantitative Evaluation Of Public Health Strategies Against HIV/AIDS In Australia: Assessing The Past, Understanding The Present And Planning For The Future
Funder
National Health and Medical Research Council
Funding Amount
$407,358.00
Summary
The overall goal of this project is to develop and implement a system which will make optimal use of all available data on HIV/AIDS from different sources in Australia, uniquely integrate the data routinely into an innovative evaluation framework which will be developed using best modelling and economic practices, and conduct analyses which will improve the effectiveness and efficiency of Australia’s HIV policy and program response to prevent new infections and plan for clinical care required fo ....The overall goal of this project is to develop and implement a system which will make optimal use of all available data on HIV/AIDS from different sources in Australia, uniquely integrate the data routinely into an innovative evaluation framework which will be developed using best modelling and economic practices, and conduct analyses which will improve the effectiveness and efficiency of Australia’s HIV policy and program response to prevent new infections and plan for clinical care required for people living with HIV.Read moreRead less